GlassScriptPhysician profile
Ethan P Levine
NPI 1144238577
$16,739.13
in general payments reported to CMS, 2019-2025
20 companies · $1,496 in 2025
The $1,496 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,604 · 2020: $569 · 2021: $850 · 2022: $1,254 · 2023: $3,543 · 2024: $6,421 · 2025: $1,496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,720 · Food and Beverage: $4,741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,719.84 |
| Food and Beverage | $4,740.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,021.65 | 2021-2025 | Micra, Pulseselect, Linq II |
| Boston Scientific Corporation | $3,918.96 | 2019-2025 | Farapulse, Rhythmia Mapping System, Watchman Flx |
| Biosense Webster, INC. | $3,190.85 | 2019-2025 | Carto 3, Qdot Micro Catheter, Octaray Mapping Catheter |
| Abbott Laboratories | $2,228.16 | 2019-2023 | Aveir |
| Medtronic Vascular, INC. | $1,502.70 | 2019-2020 | |
| Medical Device Business Services, INC. | $618.06 | 2023 | Carto 3 |
| Zoll Respicardia, INC. | $296.12 | 2021 | |
| Atricure, INC. | $237.53 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $195.15 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $135.42 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $118.84 | 2019-2021 | |
| Biotronik INC. | $88.93 | 2021 | |
| Pfizer INC. | $84.76 | 2019-2022 | |
| Lundbeck LLC | $21.58 | 2019 | |
| Cordis US Corp. | $16.53 | 2024 | Mynx Venous Vcd |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $15.31 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $12.66 | 2019 | |
| Amarin Pharma, INC. | $12.62 | 2020 | |
| Sanofi-Aventis U.S. LLC | $11.68 | 2019 | |
| Amgen INC. | $11.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ethan Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.